FFO
WST icon

Fortitude Family Office’s West Pharmaceutical WST Stock Holding History

Fortitude Family Office’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.5K Buy
57
+8
+16% +$2.45K ﹤0.01% 519
2026
Q1 		$12.3K Buy
49
+17
+53% +$4.23K ﹤0.01% 577
2025
Q4 		$8.8K Sell
32
-3
-9% -$821 ﹤0.01% 618
2025
Q3 		$9.18K Buy
35
+23
+192% +$5.59K ﹤0.01% 602
2025
Q2 		$2.63K Buy
12
+1
+9% +$214 ﹤0.01% 1061
2025
Q1 		$2.46K Hold
11
– – ﹤0.01% 891
2024
Q4 		$3.6K Hold
11
– – ﹤0.01% 919
2024
Q3 		$3.3K Hold
11
– – ﹤0.01% 907
2024
Q2 		$3.62K Hold
11
– – ﹤0.01% 688
2024
Q1 		$4.35K Hold
11
– – ﹤0.01% 671
2023
Q4 		$3.87K Buy
+11
New +$3.89K ﹤0.01% 775

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fortitude Family Office's WST Position: Q2 2026 in Review

Fortitude Family Office increased its West Pharmaceutical (WST) stake by 16% in Q2 2026, buying an estimated $2.45K and bringing the position to 57 shares worth $20.5K. The position accounts for ﹤0.01% of the portfolio, ranked #519.

Fortitude Family Office first reported a position in WST in Q4 2023 and has held it in 11 quarters since. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Fortitude Family Office held 57 shares of West Pharmaceutical worth $20.5K as of Q2 2026.
  • Fortitude Family Office bought 8 West Pharmaceutical shares in Q2 2026, an estimated $2.45K.
  • West Pharmaceutical made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #519 holding.
  • Fortitude Family Office first reported a position in West Pharmaceutical in Q4 2023 and has held it in 11 quarters since.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.